Chitosan microspheres as an alveolar macrophage delivery system of ofloxacin via pulmonary inhalation

International Journal of Pharmaceutics

Volumn 441, Issue 1-2, 2013, Pages 562-569

  Park, Ju Hwan ^a   Jin, Hyo Eon ^a   Kim, Dae Duk ^a   Chung, Suk Jae ^a   Shim, Won Sik ^b   Shim, Chang Koo ^a  

^a Seoul National University   (South Korea)

^b Gachon University   (South Korea)

Author keywords

Alveolar macrophage; Chitosan; Delivery; Inhalation; Microspheres; Ofloxacin

Indexed keywords

CHITOSAN; GLUTARALDEHYDE; MICROSPHERE; OFLOXACIN; WATER OIL CREAM;

ANIMAL CELL; ANTIMICROBIAL ACTIVITY; ARTICLE; CONTROLLED STUDY; DRUG CAPSULE; DRUG DELIVERY SYSTEM; DRUG UPTAKE; IN VITRO STUDY; LUNG ALVEOLUS MACROPHAGE; NONHUMAN; PARTICLE SIZE; PRIORITY JOURNAL; RAT;

ADMINISTRATION, INHALATION; ANIMALS; ANTI-BACTERIAL AGENTS; CHITOSAN; CROSS-LINKING REAGENTS; DRUG DELIVERY SYSTEMS; GLUTARAL; MACROPHAGES, ALVEOLAR; OFLOXACIN; PARTICLE SIZE; RATS; TIME FACTORS;

EID: 84872791453     PISSN: 03785173     EISSN: 18733476     Source Type: Journal    
DOI: 10.1016/j.ijpharm.2012.10.044     Document Type: Article

References (38)

1. M. Abazinge, T. Jackson, Q. Yang, and G. Owusu-Ababio Comparison of in vitro and in vivo release characteristics of sustained release ofloxacin microspheres Drug Deliv. 7 2000 77 81
2. L.E. Bermudez Use of liposome preparation to treat mycobacterial infections Immunobiology 191 1994 578 583
3. S.E. Berning, L. Madsen, M.D. Iseman, and C.A. Peloquin Long-term safety of ofloxacin and ciprofloxacin in the treatment of mycobacterial infections Am. J. Respir. Crit. Care Med. 151 1995 2006 2009
4. S. Bhattacharjee, D. Ershov, J.V. Gucht, G.M. Alink, I.M. Rietjens, H. Zuilhof, and A.T. Marcelis Surface charge-specific cytotoxicity and cellular uptake of tri-block copolymer nanoparticles Nanotoxicology 2011 10.3109/17435390.2011.633714
5. I.D. Bianco, J. Balsinde, D.M. Beltramo, L.F. Castagna, C.A. Landa, and E.A. Dennis Chitosan-induced phospholipase A2 activation and arachidonic acid mobilization in P388D1 macrophages FEBS Lett. 466 2000 292 294
6. J.A. Champion, Y.K. Katare, and S. Mitragotri Particle shape: a new design parameter for micro-and nanoscale drug delivery carriers J. Control. Release 121 2007 3 9
7. T.L. Dawson, G.J. Gores, A.L. Nieminen, B. Herman, and J.J. Lemasters Mitochondria as a source of reactive oxygen species during reductive stress in rat hepatocytes Am. J. Physiol. Cell Physiol. 264 1993 C961 C967
8. H.J. Doh, Y. Jung, P. Balakrishnan, H.J. Cho, and D.D. Kim A novel lipid nanoemulsion system for improved permeation of granisetron Colloids Surf. B Biointerfaces 101C 2012 475 480
9. M.H. El-Shabouri Positively charged nanoparticles for improving the oral bioavailability of cyclosporin-A Int. J. Pharm. 249 2002 101 108
10. H. Gupta, M. Aqil, R.K. Khar, A. Ali, A. Bhatnagar, and G. Mittal Sparfloxacin-loaded PLGA nanoparticles for sustained ocular drug delivery Nanomedicine 6 2010 324 333
11. K. Hirota, T. Hasegawa, T. Nakajima, H. Inagawa, C. Kohchi, G. Soma, K. Makino, and H. Terada Delivery of rifampicin-PLGA microspheres into alveolar macrophages is promising for treatment of tuberculosis J. Control. Release 142 2010 339 346
12. E. Holtzman Lysosomes. In: Cellular Organelles 1989 Plenum Press New York
13. S.M. Hwang, D.D. Kim, S.J. Chung, and C.K. Shim Delivery of ofloxacin to the lung and alveolar macrophages via hyaluronan microspheres for the treatment of tuberculosis J. Control. Release 129 2008 100 106
14. S.K. Leeper-Woodford, and J.W. Mills Phagocytosis and ATP levels in alveolar macrophages during acute hypoxia Am. J. Respir. Cell Mol. Biol. 6 1992 326 334
15. S.A. Meenach, Y.J. Kim, K.J. Kauffman, N. Kanthamneni, E.M. Bachelder, and K.M. Ainslie Synthesis, optimization and characterization of camptothecin-loaded acetalated dextran porous microparticles for pulmonary delivery Mol. Pharm. 9 2012 290 298
16. M.D. Menon, J. Deepak, Singh, J. Jayesh, Parmar, D. Darshana, Hegde, A.A. Lohade, P. Soni, and A. Samad Development and evaluation of dry powder inhalation system of terbutaline sulphate for better management of asthma Int. J. Adv. Pharma. Sci. 1 2010 133 141
17. S.E. Mutsaers, and J.M. Papadimitriou Surface charge of macrophages and their interaction with charged particles J. Leukoc. Biol. 44 1988 17 26
18. P. Muttil, C. Wang, and A.J. Hickey Inhaled drug delivery for tuberculosis therapy Pharm. Res. 26 2009 2401 2416
19. Palazzo, F., Giovagnoli, S., Schoubben, A., Blasi, P., Rossi, C., Ricci, M., Development of a spray-drying method for the formulation of respirable microparticles containing ofloxacin-palladium complex. Int. J. Pharm., http://dx.doi.org/10.1016/j.ijpharm.2012.05.045, in press.
20. G. Peluso, O. Petillo, M. Ranieri, M. Santin, L. Ambrosic, D. Calabró, B. Avallone, and G. Balsamo Chitosan-mediated stimulation of macrophage function Biomaterials 15 1994 1215 1220
21. J. Plouffe, M. Herbert, T. File Jr., I. Baird, J. Parsons, J. Kahn, and K. Rielly-Gauvin Ofloxacin versus standard therapy in treatment of community-acquired pneumonia requiring hospitalization. Pneumonia Study Group Antimicrob. Agents Chemother. 40 1996 1175 1179
22. W. Rojanarat, N. Changsan, E. Tawithong, S. Pinsuwan, H.K. Chan, and T. Srichana Isoniazid proliposome powders for inhalation-preparation, characterization and cell culture studies Int. J. Mol. Sci. 12 2011 4414 4434
23. K. Sakurai, T. Maegawa, and T. Takahashi Glass transition temperature of chitosan and miscibility of chitosan/poly (N-vinyl pyrrolidone) blends Polymer 41 2000 7051 7056
24. S. Sawatdee, N. Worakul, and T. Srichana Preparation of isoniazid as dry powder formulations for inhalation by physical mixing and spray drying Malays. J. Pharm. Sci. 4 2006 43 63
25. Y. Shibata, L.A. Foster, W.J. Metzger, and Q.N. Myrvik Alveolar macrophage priming by intravenous administration of chitin particles, polymers of N-acetyl-d-glucosamine, in mice Infect. Immun. 65 1997 1734 1741
26. J. Singh, and P. Dutta Preparation, antibacterial and physicochemical behavior of chitosan/ofloxacin complexes Int. J. Polym. Mater. 59 2010 793 807
27. Snell, N., Ganderton, D., 1999. Assessing lung deposition of inhaled medications: consensus statement from a workshop of the British Association for Lung Research, held at the Institute of Biology, London, UK on 17 April 1998. Respir. Med. 93, 123-133.
28. C.M. Stoscheck Quantitation of protein Methods Enzymol. 182 1990 50 68
29. J. T'Jonck, and F. Willems Ofloxacin in the treatment of acute exacerbations of chronic bronchitis: efficacy and safety of a once-daily regimen Curr. Ther. Res. 54 1993 265 271
30. H. Tomioka Prospects for development of new antimycobacterial drugs J. Infect. Chemother. 6 2000 8 20
31. H. Ueno, T. Mori, and T. Fujinaga Topical formulations and wound healing applications of chitosan Adv. Drug Deliv. Rev. 52 2001 105 115
32. A.S. Vilarica, N. Diogo, M. Andre, and J. Pina Adverse reactions to antituberculosis drugs in in-hospital patients: severity and risk factors Rev. Port. Pneumol. 16 2010 431 451
33. S.P. Vyas, M.E. Kannan, S. Jain, V. Mishra, and P. Singh Design of liposomal aerosols for improved delivery of rifampicin to alveolar macrophages Int. J. Pharm. 269 2004 37 49
34. H. Yamamoto, Y. Kuno, S. Sugimoto, H. Takeuchi, and Y. Kawashima Surface-modified PLGA nanosphere with chitosan improved pulmonary delivery of calcitonin by mucoadhesion and opening of the intercellular tight junctions J. Control. Release 102 2005 373 381
35. Y.Y. Yang, T.S. Chung, X.L. Bai, and W.K. Chan Effect of preparation conditions on morphology and release profiles of biodegradable polymeric microspheres containing protein fabricated by double-emulsion method Chem. Eng. Sci. 55 2000 2223 2236
36. W.W. Yew, C.K. Chan, C.H. Chau, C.M. Tam, C.C. Leung, P.C. Wong, and J. Lee Outcomes of patients with multidrug-resistant pulmonary tuberculosis treated with ofloxacin/levofloxacin-containing regimens Chest 117 2000 744 751
37. X.M. Zeng, G.P. Martin, S.K. Tee, and C. Marriott The role of fine particle lactose on the dispersion and deaggregation of salbutamol sulphate in an air stream in vitro Int. J. Pharm. 176 1998 99 110
38. L. Ziganshina, and S. Squire Fluoroquinolones for treating tuberculosis Cochrane Database Syst. Rev. 1 2008 CD004795